Does Januvia For Type 2 Diabetes Cause Pancreatic Cancer?
Diabetes
Detailed Answer:
There is no concrete proof that januvia causes pancreatic cancer. Further it is not scientifically possible that januvia is preventing your glucose from coming below 100. I understand what you are trying to say though and it sounds like a logical conclusion from what you have been told about januvia. However I wish to clarify that the real meaning of that is that it cannot cause low glucose reactions in and of itself. And regarding your question about alternative medications for diabetes, there are several such classes. Examples include SGLT2 inhibitors, Alpha glucosidase inhibitors, thiazolidenediones and bile acid sequestrants to name a few. Check with your endocrinologist if you are a candidate for some of these and especially those in the sulfonylurea and meglitinide categories
Follow up
Detailed Answer:
When I see someone like you in my practice, I typically optimize the dose of metformin to at least 2 grams total in two divided doses, provided there is no medical condition that precludes the use of metformin, such as kidney/lung/liver or heart failure. The other circumstance is where an individual has been unable to tolerate higher doses of metformin due to gut related side effects like diarrhea.
So far no diabetes medication has been proven to protect the pancreas in humans, in the context of what you are saying.
But yes, no family of medications other than incretin mimetics have been shown to have purported associations with pancreatic cancer
Second follow up
Detailed Answer:
Yes , the SGLT2 inhibitors class of medications I was referring to includes Invokana. There are couple other medicines in this category available in USA.
Check with your endocrinologist if this is a suitable option for you. (S)he will discuss the risks and benefits with you and then you can make an informed decision if this medication is something you wish to try.
Third follow up
Detailed Answer:
No. Incretin mimetics include 2 categories of medications. One is DPP4 inhibitors and the other is GLP1 analogues.
Invokana belongs to a different class of medicines called SGLT2 inhibitors